Table 60Study characteristics, outcomes, and quality ratings of adult subpopulations with rheumatoid arthritis: By concomitant therapies

StudyStudy Design
N
Duration
Study PopulationInterventionOutcomesQuality Rating
Tesser et al., 2004343RCT
1,399
6 months
Adults with RA taking or not taking antihypertensive, antidiabetic, or statin pharma-cotherapiesANK, 100mg/dayNo significant difference found in safety profilesFair

ANK = anakinra; RA = rheumatoid arthritis; RCT = randomized controlled trial

From: Results

Cover of Drug Therapy for Rheumatoid Arthritis in Adults: An Update
Drug Therapy for Rheumatoid Arthritis in Adults: An Update [Internet].
Comparative Effectiveness Reviews, No. 55.
Donahue KE, Jonas DE, Hansen RA, et al.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.